Evidence map›Paper›PMID 35406278›Full record

ArticlePolymers2022

Nanomicelles of Radium Dichloride [

Bárbara Nayane Rosário Fernandes Souza, Elisabete Regina Fernandes Ramos Ribeiro, Aline Oliveira da Silva de Barros, Martha Sahylí Ortega Pijeira, Hericka Oliveira Kenup-Hernandes, Eduardo Ricci-Junior, Joel Félix Silva Diniz Filho, Clenilton Costa Dos Santos, Luciana Magalhães Rebelo Alencar, Mohamed F Attia and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Polymers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Small science · 2025
    Review
  3. Review
  4. Review
  5. Study ofMaterials (Basel, Switzerland) · 2022
    Article
  6. Radionuclides for Targeted Therapy: Physical Properties.Molecules (Basel, Switzerland) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Bárbara Nayane Rosário Fernandes SouzaArgonauta Nuclear Reactor Center, Nuclear Engineering Institute, Brazilian Nuclear Energy Commission, Rio de Janeiro 21941-906, Brazil.ORCID 0000-0002-6366-2533
Elisabete Regina Fernandes Ramos RibeiroArgonauta Nuclear Reactor Center, Nuclear Engineering Institute, Brazilian Nuclear Energy Commission, Rio de Janeiro 21941-906, Brazil.
Aline Oliveira da Silva de BarrosArgonauta Nuclear Reactor Center, Nuclear Engineering Institute, Brazilian Nuclear Energy Commission, Rio de Janeiro 21941-906, Brazil.
Martha Sahylí Ortega PijeiraArgonauta Nuclear Reactor Center, Nuclear Engineering Institute, Brazilian Nuclear Energy Commission, Rio de Janeiro 21941-906, Brazil.ORCID 0000-0001-9307-4954
Hericka Oliveira Kenup-HernandesLaboratory of Nanoradiopharmaceuticals and Synthesis of Novel Radiopharmaceuticals, Nuclear Engineering Institute, Brazilian Nuclear Energy Commission, Rio de Janeiro 21941-906, Brazil.
Eduardo Ricci-JuniorDEFARMED Laboratory, Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-900, Brazil.ORCID 0000-0002-2550-696X
Joel Félix Silva Diniz FilhoLaboratory of Biophysics and Nanosystems, Department of Physics, Federal University of Maranhão, São Luís 65080-805, Brazil.
Clenilton Costa Dos SantosLaboratory of Biophysics and Nanosystems, Department of Physics, Federal University of Maranhão, São Luís 65080-805, Brazil.ORCID 0000-0002-3156-8673
Luciana Magalhães Rebelo AlencarLaboratory of Biophysics and Nanosystems, Department of Physics, Federal University of Maranhão, São Luís 65080-805, Brazil.ORCID 0000-0001-8210-2016
Mohamed F AttiaCenter for Nanotechnology in Drug Delivery, Eshelman School of Pharmacy, Division of Pharmacoengineering and Molecular Pharmaceutics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.ORCID 0000-0002-9413-6552
Sara Gemini-PiperniInstituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.
Ralph Santos-OliveiraArgonauta Nuclear Reactor Center, Nuclear Engineering Institute, Brazilian Nuclear Energy Commission, Rio de Janeiro 21941-906, Brazil.ORCID 0000-0002-0905-481X
Nuclear Engineering Institute · BRUniversidade Federal do Maranhão · BRUniversidade Federal do Rio de Janeiro · BRUniversidade Estadual da Zona Oeste · BRUniversity of North Carolina at Chapel Hill · US

Funding

National Council for Scientific and Technological Development Bolsa Produtividade
6 · The paper itself

Abstract

Alpha and beta particulate radiation are used for non-treated neoplasia, due to their ability to reach and remain in tumor sites. Radium-223 (

Indexed as

alpha–beta therapybone cancernanomicellesradioactive gold nanoparticlesradium-223 dichloride

Identifiers

PMID35406278
PMCPMC9002948
OpenAlexW4220771786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.